MYST3/CREBBP Rearranged Acute Myeloid Leukemia after Adjuvant Chemotherapy for Breast Cancer..     ///    "The MYST3/CREBBP AML tends to develop within 2 years of adjuvant chemotherapy, especially for breast cancer, without preceding myelodysplasia. "    ///    AML with t (8;16) is a specific translocation leading to formation of a fusion protein (MYST3/CREBBP). 